Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-26

Clinical Trial Update: Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of ivermectin and albendazole against onchocerciasis in the Volta Region, Ghana has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Onchocerciasis | Phase 3 | Status: COMPLETED